209 related articles for article (PubMed ID: 7578859)
1. Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?
Baranger TA; Audrain MA; Testa A; Besnier D; Guillevin L; Esnault VL
Autoimmunity; 1995; 20(1):33-7. PubMed ID: 7578859
[TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
4. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group.
Guillevin L; Lhote F; Amouroux J; Gherardi R; Callard P; Casassus P
Br J Rheumatol; 1996 Oct; 35(10):958-64. PubMed ID: 8883433
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
7. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis.
Watts RA; Jolliffe VA; Carruthers DM; Lockwood M; Scott DG
Arthritis Rheum; 1996 Jul; 39(7):1208-12. PubMed ID: 8670332
[TBL] [Abstract][Full Text] [Related]
8. Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome.
Saito R; Watanabe H; Asano T; Suzuki E; Iwadate H; Kobayashi H; Ohira H
Int J Rheum Dis; 2013 Jun; 16(3):339-46. PubMed ID: 23981757
[TBL] [Abstract][Full Text] [Related]
9. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
Savige JA; Gallicchio M; Georgiou T; Davies DJ
Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
[TBL] [Abstract][Full Text] [Related]
10. Polyarteritis nodosa and antiglomerular basement membrane disease without antineutrophil cytoplasm antibodies.
Kirkland GS; Savige J; Sinclair RA; Hennessy O
Am J Nephrol; 1996; 16(5):442-5. PubMed ID: 8886183
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome: indications for the diagnosis of microscopic polyangiitis.
Guillevin L; Lhote F; Brauner M; Casassus P
Ann Med Interne (Paris); 1995; 146(8):548-50. PubMed ID: 8734079
[TBL] [Abstract][Full Text] [Related]
13. The specificity of anti-neutrophil cytoplasm autoantibodies in systemic vasculitides.
Lai KN; Jayne DR; Brownlee A; Lockwood CM
Clin Exp Immunol; 1990 Nov; 82(2):233-7. PubMed ID: 1978701
[TBL] [Abstract][Full Text] [Related]
14. The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa.
Bakkaloglu A; Ozen S; Baskin E; Besbas N; Gur-Guven A; Kasapçopur O; Tinaztepe K
Arch Dis Child; 2001 Nov; 85(5):427-30. PubMed ID: 11668111
[TBL] [Abstract][Full Text] [Related]
15. Serum anti-lysosomal-associated membrane protein-2 antibody levels in cutaneous polyarteritis nodosa.
Kawakami T; Ishizu A; Arimura Y; Soma Y
Acta Derm Venereol; 2013 Jan; 93(1):70-3. PubMed ID: 22854803
[TBL] [Abstract][Full Text] [Related]
16. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients.
Cohen P; Guillevin L; Baril L; Lhote F; Noel LH; Lesavre P
Clin Exp Rheumatol; 1995; 13(2):193-8. PubMed ID: 7656465
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases].
Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A
Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764
[TBL] [Abstract][Full Text] [Related]
18. [Use of new diagnostic criteria for reclassification of polyarteritis nodosa].
Huang Q; Zhao L; Zhou JX; Zhao JL; Xu D; Tian XP
Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):239-242. PubMed ID: 33663173
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.
Watts R; Lane S; Hanslik T; Hauser T; Hellmich B; Koldingsnes W; Mahr A; Segelmark M; Cohen-Tervaert JW; Scott D
Ann Rheum Dis; 2007 Feb; 66(2):222-7. PubMed ID: 16901958
[TBL] [Abstract][Full Text] [Related]
20. [Polyarteritis nodosa].
Murakami M; Ozaki S; Nakao K
Nihon Rinsho; 1999 Feb; 57(2):349-54. PubMed ID: 10078003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
